From: Management and outcomes of myocardial infarction in people with impaired kidney function in England
Subgroup | eGFR category | Deaths, n (row %) | Total number of people | Age and sex adjusted, OR (95% CI) | Adjusteda, OR (95% CI) |
---|---|---|---|---|---|
Overall | 1–2 | 399 (11) | 3,574 | 1 | 1 |
3a | 231 (19) | 1,193 | 1.30 (1.08–1.56) | 1.28 (1.06–1.54) | |
3b | 183 (25) | 721 | 1.60 (1.30–1.97) | 1.51 (1.22–1.87) | |
4–5 | 94 (27) | 347 | 2.00 (1.53–2.62) | 1.80 (1.37–2.38) | |
AMI subtype | |||||
 STEMI | 1–2 | 174 (13) | 1,339 | 1 | 1 |
3a | 75 (24) | 314 | 1.34 (0.97–1.86) | 1.26 (0.91–1.76) | |
3b | 55 (35) | 159 | 1.81 (1.20–2.71) | 1.63 (1.09–2.43) | |
4–5 | 22 (31) | 70 | 1.93 (1.08–3.46) | 1.31 (0.73–2.38) | |
 NSTEMI | 1–2 | 225 (10) | 2,235 | 1 | 1 |
3a | 156 (18) | 879 | 1.35 (1.07–1.70) | 1.33 (1.06–1.68) | |
3b | 128 (23) | 562 | 1.64 (1.27–2.13) | 1.56 (1.20–2.02) | |
4–5 | 72 (26) | 277 | 2.20 (1.58–3.07) | 2.07 (1.50–2.86) |